19/01/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

19/01/2025

Jan 19, 2025, 23:12 | Career
Kimryn Rathmell Steps Down as NCI Director, Concluding a Pivotal Leadership Era
In a recent announcement, W. Kimryn Rathmell shared that she will be stepping down as…
Jan 19, 2025, 23:07 | Blog
Antonio D'Alessio: Our work on neoadjuvant ICI in HCC has been chosen for the 2025 ASCO GI Merit Award
Antonio D'Alessio, Medical Oncologist and PhD student at Imperial College London, shared a post on…
Jan 19, 2025, 22:56 | Science
Bevacizumab and carboplatin-pemetrexed chemotherapy with or without atezolizumab in pleural mesothelioma
Jarushka Naidoo, Professor in RCSI and Adjunct Professor of Oncology at Johns Hopkins University, shared…
Jan 19, 2025, 22:23 | Blog
Stephen Liu: Explore the latest in lung cancer care at 2025 Texas Lung Cancer Conference
Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post by IDEOlogy Health,…
Jan 19, 2025, 22:19 | Blog
Kristy Hunter: ICD-10-CM Codes for BRCA Mutation
Kristy Hunter, Outpatient Coder for HCCS, shared on LinkedIn: "I thought I would share a…
Jan 19, 2025, 22:15 | Insight
HER2-negative breast cancers show 17q12 deletion and ERBB2 loss
A recent paper by X. Qiu et al. was mentioned by Elisabetta Bonzano, Radiation Oncologist at…
Jan 19, 2025, 22:11 | Insight
Nico Gagelmann: Ide-cel versus cilta-cel for relapsed or refractory multiple myeloma
Nico Gagelmann, Chair of the CAR-T for plasma cell disorder committee at The EBMT, shared…
Jan 19, 2025, 22:04 | Insight
Chiaojung Jillian Tsai: TACE combined with Lenvatinib and Pembrolizumab vs Placebo for HCC
Chiaojung Jillian Tsai, Lead of the Allan and Ruth Kerbel Palliative RT and Oligomet Program…
Jan 19, 2025, 22:02 | Insight
FDA approved AstraZeneca’s Calquence (acalabrutinib) for adult patients with previously-treated mantle cell lymphoma
AstraZeneca’s CALQUENCE (acalabrutinib) in combination with bendamustine and rituximab was approved in the US for…
Jan 19, 2025, 21:04 | Insight
Al-Ola Abdallah discusses the AURIGA Study on multiple myeloma
Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT…
All: 74 Posts: 1 - 10
Special Coverage